Ferring Pharmaceuticals is a biopharmaceutical company dedicated to the development of innovative treatments in the areas of Gastroenterology, Reproductive Health, Urology/Oncology, Endocrinology and Orthopaedics. Ferring headquarters operates from Saint-Prex, Switzerland and its products are available in 110 countries.
http://www.ferring.com/en/about-ferring/ (link to Ferring Corporate video)
In Australia, Ferring Pharmaceuticals markets PENTASA® (mesalazine) and CORTIMENT® (oral budesonide) indicated for the treatment of Inflammatory Bowel Disease (IBD), PICOSALAX® (sodium picosulfate/magnesium citrate), KLYX® (docusate sodium/sorbitol), Fleet® enema and Phospho®-soda (sodium phosphate monobasic & dibasic) for bowel cleansing, and GLYPRESSIN® Solution (terlipressin) indicated for the treatment of bleeding oesophageal varices (BOV) and hepatorenal syndrome (HRS).
Ferring is a proud Gold Sponsor of GESA AGW 2018. Please visit us at stand 33.
Ferring Pharmaceuticals Pty Ltd
Suite 2, Level 1, Building 1,
20 Bridge Street
Pymble NSW 2073
Tel: 61 2 9497 2300
Fax: 61 2 9497 2399
Free phone: 1800 33 77 46